X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs PLETHICO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA PLETHICO PHARMA ELDER PHARMA/
PLETHICO PHARMA
 
P/E (TTM) x -0.2 -1.1 - View Chart
P/BV x 0.1 0.0 602.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   PLETHICO PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
PLETHICO PHARMA
Mar-14
ELDER PHARMA/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs380395 96.2%   
Low Rs18831 600.6%   
Sales per share (Unadj.) Rs491.2604.4 81.3%  
Earnings per share (Unadj.) Rs-3.232.5 -9.8%  
Cash flow per share (Unadj.) Rs14.451.3 28.1%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.5473.6 79.5%  
Shares outstanding (eoy) m20.5434.08 60.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.60.4 164.0%   
Avg P/E ratio x-89.36.6 -1,360.5%  
P/CF ratio (eoy) x19.74.2 474.7%  
Price / Book Value ratio x0.80.5 167.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,8337,262 80.3%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1791,596 136.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,08920,598 49.0%  
Other income Rs m257386 66.4%   
Total revenues Rs m10,34620,984 49.3%   
Gross profit Rs m-7922,818 -28.1%  
Depreciation Rs m361642 56.3%   
Interest Rs m2,7561,593 173.0%   
Profit before tax Rs m-3,653969 -377.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125-138 -90.4%   
Profit after tax Rs m-651,107 -5.9%  
Gross profit margin %-7.813.7 -57.4%  
Effective tax rate %-3.4-14.3 24.0%   
Net profit margin %-0.65.4 -12.1%  
BALANCE SHEET DATA
Current assets Rs m9,24018,877 48.9%   
Current liabilities Rs m9,99811,896 84.0%   
Net working cap to sales %-7.533.9 -22.2%  
Current ratio x0.91.6 58.2%  
Inventory Days Days4636 128.9%  
Debtors Days Days60198 30.3%  
Net fixed assets Rs m10,1249,861 102.7%   
Share capital Rs m206341 60.4%   
"Free" reserves Rs m5,58212,331 45.3%   
Net worth Rs m7,73416,139 47.9%   
Long term debt Rs m4,8894,706 103.9%   
Total assets Rs m22,88233,146 69.0%  
Interest coverage x-0.31.6 -20.2%   
Debt to equity ratio x0.60.3 216.8%  
Sales to assets ratio x0.40.6 71.0%   
Return on assets %11.88.1 144.4%  
Return on equity %-0.86.9 -12.3%  
Return on capital %22.312.3 181.5%  
Exports to sales %3.021.4 14.2%   
Imports to sales %0.415.2 2.8%   
Exports (fob) Rs m3074,402 7.0%   
Imports (cif) Rs m433,136 1.4%   
Fx inflow Rs m3074,402 7.0%   
Fx outflow Rs m1253,184 3.9%   
Net fx Rs m1811,219 14.9%   
CASH FLOW
From Operations Rs m11,7542,437 482.2%  
From Investments Rs m-561-6,265 8.9%  
From Financial Activity Rs m-6,7622,490 -271.5%  
Net Cashflow Rs m4,432-1,337 -331.4%  

Share Holding

Indian Promoters % 39.6 82.7 47.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 4.3 174.4%  
FIIs % 16.8 5.5 305.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 7.5 481.3%  
Shareholders   16,479 10,665 154.5%  
Pledged promoter(s) holding % 77.6 85.7 90.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  CIPLA  TORRENT PHARMA  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - ASTRAZENECA PHARMA COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS